Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesThe Relationship Between the Local and Systemic Inflammatory Responses and Survival in Patients Undergoing Curative Surgery for Colon and Rectal Cancers
Journal of Gastrointestinal Surgery, 09/23/09
Roxburgh CSD et al. – Local and systemic inflammatory responses are important independent predictors of survival in colon and rectal cancers. These scores combined with tumor–node–metastases stage improve the prediction of survival in these patients.
Related Articles
Visceral Fat Volume and the Prevalence of Colorectal Adenoma
American Journal of Epidemiology, 11/19/09
Relevance Score: 68%
P73 expression and its clinical significance in colorectal cancer
Colorectal Disease, 10/19/09
Relevance Score: 68%
Surgical management of colorectal liver metastases
Community Oncology, 10/09/09
Relevance Score: 68%
The effect of aspirin in the recurrence of colorectal adenomas: a meta-analysis of randomized controlled trials
Colorectal Disease, 10/15/09
Relevance Score: 67%
Aspirin as Colorectal Cancer Adjuvant Therapy
Gastroenterology, 10/05/09
Relevance Score: 67%
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of a Solitary Bone Metastasis to the Tibia from Colorectal Cancer
Case Reports in Gastroenterology, 11/25/09
Impact of Palliative Chemotherapy and Surgery on Management of Stage IV Incurable Colorectal Cancer
Annals of Surgical Oncology, 11/25/09
KRAS Mutational Status as a Predictor of Epidermal Growth Factor Receptor Inhibitor Efficacy in Colorectal Cancer
American Journal of Therapeutics, 11/25/09
Sponsor
Article Search
Sponsor